Arteriovenous Malformations (AVMs)

IWBCA
Feb 17
11 min read

Arteriovenous malformations are abnormal tangles of arteries and veins that bypass the normal capillary bed, creating high-flow shunts that can lead to brain bleeding, seizures, and other neurological problems, and that require highly individualized decisions about diagnosis, monitoring, and treatment.

Overview

What are arteriovenous malformations?

Arteriovenous malformations are clusters of abnormal blood vessels in which arteries connect directly to veins without a normal capillary network in between. This creates a high-flow, low-resistance shunt that exposes thin-walled veins to arterial pressure, thereby increasing the risk of rupture and hemorrhage. In the brain and spinal cord, these lesions are often referred to as cerebral or intracranial AVMs. Most brain AVMs are thought to be congenital, although many are not detected until adolescence or adulthood.

AVMs are relatively uncommon but clinically important. Population-based estimates suggest an incidence of approximately 1 case per 100,000 persons per year and a point prevalence in adults of approximately 18 per 100,000. Brain AVMs account for a small percentage of all strokes overall but represent a leading cause of hemorrhagic stroke in children and young adults.

Brain AVMs can occur in any region, including superficial cortical areas, deep structures such as the basal ganglia or thalamus, and the brainstem or cerebellum. AVMs may also occur in the spinal cord or other organs, particularly in some inherited vascular syndromes. The clinical significance and treatment options depend heavily on the AVM’s size, location, pattern of blood flow, and prior history of hemorrhage. Management decisions often follow specialized grading systems such as the Spetzler–Martin scale, which estimate surgical risk based on size, venous drainage, and proximity to the brain.

Anatomy

Feeding Arteries: Feeding arteries are the arterial vessels that deliver blood into the AVM. They often arise from normal cerebral arteries but may become enlarged and tortuous over time because of chronically increased flow. The number, size, and accessibility of these arteries influence both hemorrhage risk and treatment strategy, especially for surgical or endovascular approaches.
Nidus: The nidus is the core tangle of abnormal vessels where arteries and veins intermingle. It lacks a normal capillary structure and forms a complex network of small channels that allow high-pressure blood to pass directly into the venous system. The nidus can be compact or diffuse, and these features affect the feasibility and risk of surgery, embolization, or radiosurgery.
Draining Veins: Draining veins carry blood away from the nidus into the normal venous circulation. These veins are often dilated and may have thin, fragile walls due to chronic exposure to arterial pressure. Deep venous drainage and restricted outflow are associated with higher hemorrhage risk and are central elements in grading systems and risk prediction tools.

Symptoms

What are the most common symptoms associated with this condition?

Symptoms of brain AVMs vary widely. Some individuals remain asymptomatic and are diagnosed incidentally on imaging performed for unrelated reasons. Others present with acute, life-threatening intracranial hemorrhage. Between these extremes, AVMs can cause seizures, chronic or recurrent headaches, and progressive or fluctuating neurological deficits such as weakness, sensory loss, or visual field disturbances. The pattern of symptoms is strongly influenced by the AVM’s location, size, and whether it has ruptured.

Intracranial Hemorrhage: Hemorrhage is one of the most common and devastating presentations of brain AVMs. Bleeding can occur into brain tissue, the ventricular system, or surrounding spaces, leading to sudden severe headache, vomiting, decreased level of consciousness, focal neurological deficits, or coma. AVM-related hemorrhage is a major cause of stroke in younger adults and children and can result in long-term disability or death.
Seizures and Epilepsy: Seizures are another frequent manifestation, especially when AVMs involve or irritate cortical regions. People may experience focal seizures with or without impaired awareness or generalized tonic–clonic seizures. Over time, recurrent seizures can lead to a diagnosis of epilepsy. Annual seizure risk in individuals with cerebral AVMs is estimated at around 1 percent, and seizures may precede or follow a hemorrhagic event.
Headache and Focal Neurological Symptoms: Some individuals report chronic or recurrent headaches, which may be localized or migraine-like. Focal neurological symptoms such as weakness, numbness, visual changes, language difficulties, or balance problems can arise from the AVM’s mass effect, local ischemia, or small, clinically silent hemorrhages that accumulate over time. These symptoms often reflect the specific brain region affected by the AVM.
Incidental and Asymptomatic AVMs: A substantial number of AVMs are discovered incidentally during imaging performed for unrelated reasons, such as evaluation of head trauma or headaches from other causes. In asymptomatic cases of unruptured AVM, the central concern is estimating the future risk of hemorrhage or other complications and weighing that risk against the potential harms of intervention. This balance is particularly complex for small, deep, or eloquent-area AVMs where treatment carries significant procedural risk.

Causes and Pathophysiology

What causes arteriovenous malformations?

For most people, brain AVMs are believed to arise from abnormal vascular development during embryogenesis or early life, rather than from acquired injury in adulthood. In many cases, no identifiable trigger is identified, and the AVM is classified as sporadic. In others, AVMs occur as part of broader hereditary vascular or connective tissue syndromes. Regardless of cause, the core pathophysiologic feature is an arteriovenous shunt without a normal capillary bed, which alters local hemodynamics and vessel wall biology.

Congenital Vascular Development Abnormalities: Most cerebral AVMs are thought to reflect errors in vascular morphogenesis that occur during the differentiation of primitive vascular networks into distinct arterial, capillary, and venous systems. Instead of maturing into a low-pressure capillary bed, the region retains a plexus of high-flow channels, resulting in a tangle of arteries and veins. These abnormalities may remain clinically silent for years until changes in pressure, flow, or vessel wall integrity lead to symptoms or hemorrhage.
Inherited Syndromes and Genetic Factors: A subset of AVMs occurs in the context of hereditary vascular syndromes, such as hereditary hemorrhagic telangiectasia, in which mutations in genes that regulate angiogenesis and vascular integrity predispose to AVMs in the brain, lungs, liver, or other organs. Familial clustering of cerebral AVMs has also been reported, suggesting that genetic susceptibility may play a role in at least some cases.
Hemodynamic Stress and Vessel Wall Changes: High-flow shunting through the nidus chronically increases shear stress and pressure on the feeding arteries and draining veins. Over time, these forces can lead to progressive vessel dilation, venous wall thinning, and the development of weak points prone to rupture. Venous outflow restriction and deep venous drainage patterns further amplify local hemodynamic stress, which has been associated with an increased risk of hemorrhage.
Brain Tissue and Neurovascular Effects: Surrounding brain tissue may experience chronic hypoperfusion or “steal” phenomena, where blood is preferentially diverted through the low-resistance AVM shunt rather than perfusing adjacent cortex. This can contribute to focal neurological deficits, cognitive changes, or seizure activity. Repeated small bleeds and gliosis around the nidus also alter local neurovascular coupling and may increase seizure propensity.

Risk Factors

Who is at increased risk of developing or experiencing complications from an AVM?

Because most brain AVMs are believed to be congenital, traditional cardiovascular risk factors such as hypertension and hyperlipidemia are not thought to cause the malformation itself. Instead, risk discussions focus on who is more likely to harbor an AVM and which features increase the likelihood of hemorrhage or other complications once an AVM is present.

Age and Life Stage: AVMs can present at any age but are often first identified in adolescence, young adulthood, or midlife. Hemorrhage from an AVM is an important cause of stroke in younger patients who otherwise lack typical vascular risk factors. Because hemorrhage risk accumulates over time, younger individuals with unruptured AVMs face a substantial lifetime cumulative risk, even if the annual risk in any given year appears modest.
Prior Hemorrhage: A history of prior AVM-related hemorrhage is one of the strongest predictors of future bleeding. Large natural history studies suggest that previously ruptured AVMs may have an annual hemorrhage risk in the range of 4 to 6 percent or higher, compared with about 1 to 3 percent per year for unruptured lesions, although estimates vary across cohorts.
AVM Angioarchitectural Features: Angiographic characteristics strongly influence hemorrhage risk. Deep location, deep venous drainage, associated intranidal or feeding-artery aneurysms, and venous outflow obstruction have all been correlated with higher bleeding rates. These features are incorporated into various hemorrhage risk scores and grading systems that help estimate risk and guide treatment planning.
Genetic and Syndromic Associations: Individuals with hereditary hemorrhagic telangiectasia or other inherited vascular disorders have a greater likelihood of harboring AVMs in the brain and other organs. In such populations, targeted imaging screening may be recommended, particularly in families with known high-risk mutations.

Complications

What complications can arise if an AVM is present?

The principal concern with brain AVMs is the risk of intracranial hemorrhage, which can be catastrophic. However, even in the absence of bleeding, AVMs can lead to seizures, chronic neurological deficits, cognitive or psychological effects, and quality-of-life impairment. Complications may also result from diagnostic procedures or interventions, especially when lesions are large, deep, or located in eloquent brain regions.

Intracerebral and Subarachnoid Hemorrhage: AVM rupture can cause bleeding into brain tissue, the ventricles, or the subarachnoid space. Acute hemorrhage may result in elevated intracranial pressure, herniation, and death if not managed promptly. Survivors can be left with long-term motor, sensory, language, or cognitive deficits that depend on the location and extent of the bleed.
Recurrent Hemorrhage: After an initial bleed, AVMs remain at risk for re-hemorrhage, particularly in the first months and years that follow. Studies of ruptured high-grade AVMs report annualized re-rupture risks that can exceed 6 percent, with the highest risk often in the first year. Each subsequent hemorrhage carries additional risk of disability and mortality.
Seizure Disorders and Neurocognitive Impact: Chronic seizures and epilepsy associated with AVMs can impair quality of life and may affect employment, driving, and independence. In addition, both hemorrhagic and non-hemorrhagic AVMs can lead to neurocognitive deficits, mood disorders, and fatigue, particularly when lesions or treatment involve the frontal or temporal lobes.
Procedure-Related Complications: Interventions such as microsurgical resection, endovascular embolization, and stereotactic radiosurgery carry risks that include stroke, new neurological deficits, hemorrhage, and, less commonly, death. These risks are strongly influenced by AVM grade, patient comorbidities, and operator experience. Decision-making requires careful comparison of natural-history risk with procedural risk, often within a multidisciplinary center.

Diagnosis and Testing

How are arteriovenous malformations diagnosed and evaluated?

Brain AVMs are usually evaluated with neuroimaging that can visualize both brain tissue and the structure of cerebral vessels. The goals of diagnostic workup are to confirm the presence of an AVM, characterize its anatomy and flow patterns, evaluate for associated aneurysms, and assess the effects of prior or current hemorrhage. This information is essential for risk estimation and treatment planning.

Initial Brain Imaging: Non-contrast CT is frequently the first imaging modality in individuals presenting with acute neurological symptoms, particularly when suspected hemorrhage is a concern. It can identify intracerebral or subarachnoid bleeding and may provide indirect evidence of an underlying vascular malformation. MRI offers greater detail about parenchymal changes, prior microhemorrhages, and the relationship between the AVM and surrounding brain structures.
Vascular Imaging with CTA or MRA: CT angiography and MR angiography are noninvasive techniques that visualize cerebral arteries and veins. They can usually demonstrate the core nidus, feeding arteries, and draining veins and may identify associated aneurysms. These modalities are often used to screen for AVMs, to follow known lesions, and to plan more definitive studies.
Catheter Cerebral Angiography: Digital subtraction angiography remains the gold standard for detailed evaluation of AVMs. It provides dynamic, high-resolution images of arterial inflow, nidus configuration, venous drainage patterns, and associated aneurysms. Angiographic information guides grading, risk stratification, and treatment planning and is usually required before major interventions.
Functional and Adjunctive Assessment: In some centers, advanced techniques such as functional MRI, diffusion tensor imaging, or intraoperative mapping help define the relationship between the AVM and eloquent cortex or white matter tracts. This information is particularly valuable when considering surgery or radiosurgery near language, motor, or visual pathways.

Management and Treatment

What are the main treatment options, and how are decisions made?

Management of brain AVMs is highly individualized. Choices range from careful observation with periodic imaging to aggressive multimodal treatment involving surgery, embolization, and radiosurgery. The central question is whether the long-term risk of hemorrhage and other complications from the AVM outweighs the procedural risks of intervention, a balance that often differs between ruptured and unruptured lesions. Current recommendations emphasize shared decision-making in experienced multidisciplinary teams, guided by evidence and consensus statements from organizations such as the American Heart Association and the American Stroke Association.

Observation and Conservative Management: For some unruptured AVMs, particularly small, deep, or adjacent to highly eloquent brain regions, conservative management with clinical and imaging follow-up may be reasonable. Randomized and observational studies have highlighted that for certain unruptured lesions, the procedural risks of intervention may exceed the natural-history risk of hemorrhage, particularly over shorter time horizons. In such cases, careful monitoring and aggressive management of comorbidities are prioritized.
Microsurgical Resection: Open neurosurgical removal of an AVM can eliminate the risk of hemorrhage immediately upon complete resection. Surgery typically yields the best outcomes for low-grade AVMs in non-eloquent locations, particularly Spetzler–Martin grades I and II, where cure rates are high and procedural risk is relatively low. Higher-grade lesions have markedly greater surgical risk, and decisions must be made cautiously with attention to predicted neurological outcomes.
Endovascular Embolization: Endovascular therapy involves navigating microcatheters into feeding arteries and injecting embolic materials to occlude parts of the nidus or associated aneurysms. Embolization is frequently used as an adjunct to surgery or radiosurgery to reduce flow, shrink the nidus, or treat high-risk aneurysms. In selected cases, curative embolization may be feasible; however, incomplete treatment can leave residual risk and complicate subsequent interventions.
Stereotactic Radiosurgery: Stereotactic radiosurgery delivers focused radiation to the nidus with the goal of inducing gradual vessel closure. This approach is particularly useful for small to moderate-sized AVMs located in deep or eloquent regions, where surgery would be high-risk. Obliteration typically occurs over 2 to 3 years, during which hemorrhage risk persists, so radiosurgery is best suited for carefully selected lesions with acceptable interim risk.
Multimodal and Staged Approaches: Many AVMs, especially complex or high-grade lesions, are treated with combinations of these modalities. Embolization may precede surgery to reduce intraoperative bleeding or radiosurgery to reduce nidus size. Treatment is often staged over multiple sessions, and re-imaging is used to verify obliteration and identify any residual shunt that may require further intervention.

Outlook and Prognosis

What is the long-term outlook for people with arteriovenous malformations?

Prognosis for individuals with brain AVMs depends on many factors, including prior hemorrhage, AVM size and location, venous drainage pattern, associated aneurysms, age, comorbidities, and the safety and success of any interventions. Some people live their entire lives with an unruptured, stable AVM and minimal symptoms, while others experience early catastrophic hemorrhage or treatment-related complications.

Natural History and Hemorrhage Risk Over Time: Across large cohorts, the annual risk of hemorrhage for untreated AVMs has often been estimated in the range of 2 to 4 percent, with lower risks for unruptured lesions and higher risks for those with prior bleeding or high-risk angioarchitecture. Although the annual percentage may appear modest, the cumulative lifetime risk can be substantial, particularly among younger individuals. This cumulative risk is a key driver of discussions about whether and when to intervene.
Outcomes After Hemorrhage or Treatment: Functional outcomes after AVM-related hemorrhage vary widely. Some individuals recover with minimal deficits, while others experience severe disability or death. For appropriately selected low-grade AVMs, surgical or radiosurgical treatment can achieve high rates of cure with good functional outcomes. In contrast, high-grade or deeply located AVMs often carry significant risk both if left untreated and if treated, which underscores the importance of individualized counseling and specialized care.
Quality of Life and Long-Term Follow-Up: Beyond hemorrhage and mortality, quality-of-life outcomes such as cognitive function, mood, fatigue, seizure control, and social participation are increasingly recognized as critical prognostic measures. Lifelong follow-up in neurology or neurosurgery clinics is often recommended to monitor for late complications, manage seizures or neurocognitive issues, and confirm stable obliteration of treated AVMs with periodic imaging.

Seeking Care

When should someone seek urgent or specialist care for a suspected AVM?

Rapid assessment is essential when an AVM ruptures or when new neurological symptoms emerge. Even for incidentally discovered or stable lesions, evaluation in a center with cerebrovascular expertise can significantly influence diagnostic accuracy, risk estimation, and treatment planning.

Emergency Situations: Immediate medical attention is critical when a person develops a sudden, severe headache, vomiting, seizure, acute weakness, numbness, vision loss, difficulty speaking, confusion, or decreased level of consciousness. These symptoms may signal intracranial hemorrhage or acute neurological injury and warrant emergency evaluation, including brain imaging and specialist consultation.
New or Worsening Neurological Symptoms: Specialist assessment is recommended when there are new or progressive neurological symptoms such as increasing headaches, recurrent seizures, focal weakness, sensory changes, or visual disturbances, particularly in someone with a known AVM or a history of prior hemorrhage. These changes may indicate evolving hemodynamics, subtle bleeding, or other complications that require timely investigation.
Follow-Up for Known AVMs and Post-Treatment Care: Individuals with diagnosed AVMs, whether treated or observed, usually benefit from periodic follow-up with neurology and neurosurgery teams to reassess symptoms, review imaging, and adjust management plans. After surgery, embolization, or radiosurgery, long-term imaging surveillance is often needed to confirm durable obliteration and to detect any residual or recurrent shunting that might re-establish hemorrhage risk.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.